ID: ALA158793

Max Phase: Preclinical

Molecular Formula: C17H23N5O4

Molecular Weight: 361.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCOc1ccc(OCCCNc2nc(N)nc(O)c2N=O)cc1

Standard InChI:  InChI=1S/C17H23N5O4/c1-2-3-10-25-12-5-7-13(8-6-12)26-11-4-9-19-15-14(22-24)16(23)21-17(18)20-15/h5-8H,2-4,9-11H2,1H3,(H4,18,19,20,21,23)

Standard InChI Key:  MPVGBTCWEYQBBX-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydropteroate synthase 129 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 361.40Molecular Weight (Monoisotopic): 361.1750AlogP: 3.22#Rotatable Bonds: 11
Polar Surface Area: 131.95Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.91CX Basic pKa: 2.83CX LogP: 3.86CX LogD: 3.86
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.41Np Likeness Score: -0.64

References

1. Lever OW, Bell LN, Hyman C, McGuire HM, Ferone R..  (1986)  Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.,  29  (5): [PMID:3486292] [10.1021/jm00155a014]

Source